Ear Drops Beat Oral Medications in Children With Tympanostomy-Tube Otorrhea

Article

A new study suggests antibiotic-glucocorticoid ear drops are superior to oral medications in children who suffer from acute otorrhea following the insertion of tympanostomy tubes for recurrent ear infections.

A new study suggests antibiotic-glucocorticoid ear drops are superior to oral medications in children who suffer from acute otorrhea following the insertion of tympanostomy tubes for recurrent ear infections.

For their trial published Feb. 20, 2014, in The New England Journal of Medicine, Thijs van Dongen, MD, and colleagues in the Netherlands randomized children aged between 1-10 years with uncomplicated acute tympanostomy-tube otorrhea to the hydrocortisone—bacitracin–colistin ear drops, oral amoxicillin–clavulanate suspension, or an initial observational approach.

After 2 weeks, only 5% of the children who received the antibiotic-glucocorticoid ear drops still had otorrhea, compared to 44% of those who received oral antibiotics and 55% of those who underwent observation. In addition, the median duration of the initial episode of discharge from the ears was 4 days for children treated with the ear drops, versus 5 days for those who received oral antibiotics (P< 0.001) and 12 days for those assigned to initial observation (P< 0.001).

According to the authors, treatment-related adverse events were mild, and no complications of otitis media — including local cellulitis, perichondritis, mastoiditis, and intracranial complications &mdash; were reported at 2 weeks.

Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
Elizabeth Spencer, MD: Precision Medicine in Pediatric IBD
Anita Clayton, MD: Zuranolone for Postpartum Depression
Mikkael Sekeres, MD:
Lynn Malec, MD: FVIII Therapy Improves Levels in Pediatric Patients with Hemophilia A
© 2024 MJH Life Sciences

All rights reserved.